Showing 1 -
11 of 11
As part of its commitment to environmental sustainability and promoting green building practices in its more than 4,400 restaurants, this Earth Day, Tim Hortons is announcing a new initiative to replace all existing lighting fixtures in restaurants across Canada and the United States with energy-efficient light-emitting diode (LED) lighting from Philips. The conversion program will see 485 restaurants outfitted with LED lighting in 2014 alone, translating to an estimated 6.4 million kilowatt hours (kWh) in energy savings.
The Winner of the 2014 RBC Taylor Prize is Thomas King, author of The Inconvenient Indian: A Curious Account of Native People, published by Doubleday Canada. The $25,000 award was announced today in Toronto by Prize founder and chair, Noreen Taylor during a gala luncheon celebrating this year's Finalists. This was the 13th awarding of the country's most prestigious prize for literary non-fiction.
Novartis a annoncé aujourd’hui que BexseroMD (vaccin à constituants multiples contre le méningocoque B [recombinant, adsorbé]) est maintenant disponible auprès des pharmaciens et des médecins au Canada. Le vaccin est indiqué chez les personnes âgées de 2 mois à 17 ans. Le risque de contracter une infection par le méningocoque du sérogroupe B est plus élevé chez les nourrissons, les tout-petits et les adolescents. BexseroMD est le premier vaccin à large spectre qui contribue à offrir une protection contre la méningococcie causée par la souche B. Avant la mise au point de BexseroMD, les vaccins offerts permettaient de favoriser une protection seulement contre les souches A, C, W et Y.
Mississauga, ON – February 27, 2014 – Genzyme, a Sanofi company, today announced the Canadian availability of PrLEMTRADA™ (alemtuzumab) for the management of adult patients with relapsing-remitting multiple sclerosis (RRMS), with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
Novartis announced today that Bexsero® (Multicomponent Meningococcal B Vaccine [recombinant, adsorbed]) is now available to doctors and pharmacists across Canada. The vaccine is approved for use in individuals from two months through 17 years of age in Canada. Infants, toddlers and adolescents are at the greatest risk of meningococcal serogroup B (MenB) infection. Bexsero® is the first broad-coverage vaccine to help protect against MenB disease. Prior to Bexsero®, vaccines were only available to help protect against meningococcal strains A, C, W and Y.
Vapourization ensures dose consistency and minimizes health risks inherent in smoking.
CanniMed Ltd. is excited to announce an agreement with Storz & Bickel GmbH & Co. to be the exclusive Canadian distributor of the Volcano® Medic vaporizer, the only device approved by Health Canada for the consumption of medical marijuana. This premiere vaporization system gives CanniMed patients another delivery option to consume medical marijuana without the health concerns inherent in smoking.
Panama has become the latest country to adopt British Columbia’s HIV Treatment as Prevention strategy.
Panama and the BC Centre for Excellence in HIV/AIDS (BC-CfE) have signed a memorandum of understanding (MOU) to partner in the global fight against HIV/AIDS through the implementation of the made-in-B.C. strategy.
Panama becomes the first Central American country to embrace Treatment as Prevention, and joins China, France, and Brazil in adopting the strategy as their national HIV/AIDS policy. The strategy has also been implemented by cities across the United States, including San Francisco, New York City, and Washington, D.C.
The Chartered Professional Accountants of British Columbia’s budget response team provides its impressions of B.C.’s 2014 budget. CPABC’s CEO Richard Rees, CPA, FCA, comments on the short- and long-term implications of the government’s fiscal plan.
Le bulletin de cette année porte sur les résultats d’un sondage auprès de 2 000 survivants d’une crise cardiaque ou d’un AVC (et leurs proches) et aborde d’importantes questions : Les survivants sont-ils capables d’adopter et de conserver des habitudes d’importance vitale? Reçoivent-ils le soutien besoin pour un rétablissement adéquat? Le Bulletin fait le bilan de la réadaptation au Canada, examine les obstacles en matière d’accès, et présente des témoignages de survivants. L’une des survivantes est patineuse artistique et médaillée Olympique Isabelle Brasseur qui a subit un arrêt cardiaque lors de son l’accouchement. Elle est consciente de l'importance des habitudes saines et encourage tous les Canadiens à prendre leur santé à cœur.
This year’s report looks at findings from a unique poll of 2,000 heart attack and stroke survivors (and their loved ones) and answers important questions: Are survivors able to make and maintain potentially life-saving behaviour changes? Are they receiving the support they need to recover and thrive to the fullest? This year’s Report also investigates the current state of rehabilitation in Canada and challenges around access and personal stories from survivors. One such survivor is Olympic figure skater Isabelle Brasseur, who suffered cardiac arrest while giving birth to her daughter. She knows first-hand te importance of maintaining heart healthy behaviours and speaks to her experiences and encourages all Canadians to take their health to heart.
There is currently no broadcast quality footage hosted at this URL. An advisory will be issued when a footage has been released.